Global Ocular Drug Delivery Devices Market Growth 2025-2031

Publication ID:

LPI04250542

Publication Date:

April 1, 2025

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Ocular Drug Delivery Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淥cular Drug Delivery Devices Industry Forecast鈥� looks at past sales and reviews total world Ocular Drug Delivery Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Ocular Drug Delivery Devices sales for 2025 through 2031. With Ocular Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ocular Drug Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Ocular Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ocular Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ocular Drug Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ocular Drug Delivery Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ocular Drug Delivery Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Ocular Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ocular Implant
Microneedle
Ocular Inserts
Punctal Plugs
Viscosurgical Devices
Others
Segmentation by Application:
Hospitals
Eye Clinics
Homecare Setting
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon Vision
Carl Zeiss
Glaukos Corporation
Ocular Therapeutix
Graybug Vision
Santen Pharmaceutical
Clearside Biomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ocular Drug Delivery Devices market?
What factors are driving Ocular Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ocular Drug Delivery Devices market opportunities vary by end market size?
How does Ocular Drug Delivery Devices break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ocular Drug Delivery Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Ocular Drug Delivery Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Ocular Drug Delivery Devices by Country/Region, 2020, 2024 & 2031
2.2 Ocular Drug Delivery Devices Segment by Type
2.2.1 Ocular Implant
2.2.2 Microneedle
2.2.3 Ocular Inserts
2.2.4 Punctal Plugs
2.2.5 Viscosurgical Devices
2.2.6 Others
2.3 Ocular Drug Delivery Devices Sales by Type
2.3.1 Global Ocular Drug Delivery Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Ocular Drug Delivery Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Ocular Drug Delivery Devices Sale Price by Type (2020-2025)
2.4 Ocular Drug Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Eye Clinics
2.4.3 Homecare Setting
2.4.4 Others
2.5 Ocular Drug Delivery Devices Sales by Application
2.5.1 Global Ocular Drug Delivery Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Ocular Drug Delivery Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Ocular Drug Delivery Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Ocular Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Ocular Drug Delivery Devices Annual Sales by Company (2020-2025)
3.1.2 Global Ocular Drug Delivery Devices Sales Market Share by Company (2020-2025)
3.2 Global Ocular Drug Delivery Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Ocular Drug Delivery Devices Revenue by Company (2020-2025)
3.2.2 Global Ocular Drug Delivery Devices Revenue Market Share by Company (2020-2025)
3.3 Global Ocular Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Ocular Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ocular Drug Delivery Devices Product Location Distribution
3.4.2 Players Ocular Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Ocular Drug Delivery Devices by Geographic Region
4.1 World Historic Ocular Drug Delivery Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Ocular Drug Delivery Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Ocular Drug Delivery Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Ocular Drug Delivery Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Ocular Drug Delivery Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Ocular Drug Delivery Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ocular Drug Delivery Devices Sales Growth
4.4 APAC Ocular Drug Delivery Devices Sales Growth
4.5 Europe Ocular Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Ocular Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Ocular Drug Delivery Devices Sales by Country
5.1.1 Americas Ocular Drug Delivery Devices Sales by Country (2020-2025)
5.1.2 Americas Ocular Drug Delivery Devices Revenue by Country (2020-2025)
5.2 Americas Ocular Drug Delivery Devices Sales by Type (2020-2025)
5.3 Americas Ocular Drug Delivery Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ocular Drug Delivery Devices Sales by Region
6.1.1 APAC Ocular Drug Delivery Devices Sales by Region (2020-2025)
6.1.2 APAC Ocular Drug Delivery Devices Revenue by Region (2020-2025)
6.2 APAC Ocular Drug Delivery Devices Sales by Type (2020-2025)
6.3 APAC Ocular Drug Delivery Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ocular Drug Delivery Devices by Country
7.1.1 Europe Ocular Drug Delivery Devices Sales by Country (2020-2025)
7.1.2 Europe Ocular Drug Delivery Devices Revenue by Country (2020-2025)
7.2 Europe Ocular Drug Delivery Devices Sales by Type (2020-2025)
7.3 Europe Ocular Drug Delivery Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ocular Drug Delivery Devices by Country
8.1.1 Middle East & Africa Ocular Drug Delivery Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Ocular Drug Delivery Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Ocular Drug Delivery Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Ocular Drug Delivery Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ocular Drug Delivery Devices
10.3 Manufacturing Process Analysis of Ocular Drug Delivery Devices
10.4 Industry Chain Structure of Ocular Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ocular Drug Delivery Devices Distributors
11.3 Ocular Drug Delivery Devices Customer
12 World Forecast Review for Ocular Drug Delivery Devices by Geographic Region
12.1 Global Ocular Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Ocular Drug Delivery Devices Forecast by Region (2026-2031)
12.1.2 Global Ocular Drug Delivery Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Ocular Drug Delivery Devices Forecast by Type (2026-2031)
12.7 Global Ocular Drug Delivery Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Alcon Vision
13.1.1 Alcon Vision Company Information
13.1.2 Alcon Vision Ocular Drug Delivery Devices Product Portfolios and Specifications
13.1.3 Alcon Vision Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alcon Vision Main Business Overview
13.1.5 Alcon Vision Latest Developments
13.2 Carl Zeiss
13.2.1 Carl Zeiss Company Information
13.2.2 Carl Zeiss Ocular Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Carl Zeiss Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Carl Zeiss Main Business Overview
13.2.5 Carl Zeiss Latest Developments
13.3 Glaukos Corporation
13.3.1 Glaukos Corporation Company Information
13.3.2 Glaukos Corporation Ocular Drug Delivery Devices Product Portfolios and Specifications
13.3.3 Glaukos Corporation Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glaukos Corporation Main Business Overview
13.3.5 Glaukos Corporation Latest Developments
13.4 Ocular Therapeutix
13.4.1 Ocular Therapeutix Company Information
13.4.2 Ocular Therapeutix Ocular Drug Delivery Devices Product Portfolios and Specifications
13.4.3 Ocular Therapeutix Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ocular Therapeutix Main Business Overview
13.4.5 Ocular Therapeutix Latest Developments
13.5 Graybug Vision
13.5.1 Graybug Vision Company Information
13.5.2 Graybug Vision Ocular Drug Delivery Devices Product Portfolios and Specifications
13.5.3 Graybug Vision Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Graybug Vision Main Business Overview
13.5.5 Graybug Vision Latest Developments
13.6 Santen Pharmaceutical
13.6.1 Santen Pharmaceutical Company Information
13.6.2 Santen Pharmaceutical Ocular Drug Delivery Devices Product Portfolios and Specifications
13.6.3 Santen Pharmaceutical Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Santen Pharmaceutical Main Business Overview
13.6.5 Santen Pharmaceutical Latest Developments
13.7 Clearside Biomedical
13.7.1 Clearside Biomedical Company Information
13.7.2 Clearside Biomedical Ocular Drug Delivery Devices Product Portfolios and Specifications
13.7.3 Clearside Biomedical Ocular Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Clearside Biomedical Main Business Overview
13.7.5 Clearside Biomedical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂